ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666870 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666870; 2) Community: the network communities that were significantly associated with the response to NSC 666870; 3) Molecule: the relationships between components within communities and NSC 666870; 4) MDR: the compounds that were significantly associated with the NSC 666870.

NSC Compound Enrichment Correlation
NSC 329261 Null 0.0489393809599837 0.15066834
NSC 33568 1-Propanone, 1,2-diphenyl-3-(1-piperidinyl)- (9CI) 0.0489393809599837 0.064995197
NSC 357704 Cyanomorpholinodoxorubicin 0.0489393809599837 0.45464577
NSC 606172 Camptothecin Derivative 0.0489393809599837 0.52090835
NSC 606985 Camptothecin Derivative 0.0489393809599837 0.45779434
NSC 613327 Gemcitabine Y 0.0489393809599837 0.52344615
NSC 618939 Camptothecin Derivative 0.0489393809599837 0.51977156
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.0489393809599837 0.26261724
NSC 646381 Null 0.0489393809599837 0.16345752
NSC 654893 Null 0.0489393809599837 0.076583928
Total:29  Current:28    [First] [Prev] [Next] [Last]